Sunday, October 19, 2025 from 2:15 p.m. to 3:45 p.m. CDT at Greenway FGHIJ, 2nd Floor
This session is being recorded.
Learn MoreAvailable for 1.50 hours of CPE creditActivity Number: 0217-0000-25-124-L01-PActivity Type: A Knowledge-Based ActivityEmerging data on the clinical benefits of incretin-based pharmacotherapy for the management of persons with overweight or obesity has brought glucagon-like peptide-1 (GLP-1) and GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonists to the forefront of patient-provider conversations, popular media, and policy discussions. Anticipated multi-society guidelines for the management of overweight and obesity and an increasingly robust pipeline of incretin-based and other peptide therapies will have a significant impact on the future of cardiometabolic care. Evidence supporting new agents for weight management, the most recent practice guidelines related to this chronic condition, and national policy updates related to coverage for these agents will be reviewed during this program. In addition, this session will allow the speakers to share their practice experience working with this patient population and allow for a discussion of the benefits and challenges of a pharmacist-led service for people who are overweight or obese.
Learning Objectives1. Discuss the mechanisms of action of newer incretin- and peptide-based therapies developed for the management of persons with overweight or obesity.
2. Review evidence supporting the use of newer incretin-based and peptide therapies in the management of persons with overweight or obesity.
3. Describe recent updates in clinical practice guidelines for the management of persons with overweight or obesity.
4. Identify changes to policies related to the coverage of pharmacotherapy for weight management and its impact on medication access.
5. Explain the impact of new evidence, practice recommendations, and policy updates to the management of overweight and obesity through a patient case.
 | | Moderator: | Sarah Jane E. Faro, Pharm.D., MS, BCOP, BCPS | | Clinical Pharmacist Practitioner, Pediatric Hematology/Oncology & Cellular Therapies
Oregon Health & Science University
Portland, OR
| | View Biography |
|
The Low-Down on Scaling Down: New Therapies for the Management of Persons with Overweight or Obesity 2:15 p.m. to 2:45 p.m. | | Speaker: | Amy K. Leung, Pharm.D., BCPS | | Clinical Pharmacist Practitioner (CPP)
Phoenix VA Health Care System
Phoenix, AZ | | View Biography |
|
|
A Long A-Weighted Update: A Review of New Clinical Practice Guidelines for the Management of Persons with Overweight or Obesity2:45 p.m. to 3:15 p.m. | | Speaker: | Abby Lennon, Pharm.D., BCACP, CDCES | | Clinical Pharmacy Specialist - Bariatrics & Endocrinology
Inova
Fairfax, VA | | View Biography |
|
|
Worth the Weight: Policy Updates on the Coverage of Medications for Weight Management and Impact on Access3:15 p.m. to 3:45 p.m. | | Speaker: | Lindsay A. Breland, Pharm.D., BCACP, BCPS | | Assistant Professor
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy
Amarillo, TX | | View Biography |
|
|